New guidelines on how to treat hereditary breast cancer could be a gamechanger.
Convenience, fewer missed appointments and lower insurance costs benefit patients and doctors. Having access to patients’ medical records, private on-camera communication, and reducing unnecessary in-office and ER visits are a few reasons telemedicine continues to grow in popularity.
Study Suggests Connection Between Ovarian Cancer and Fibrosis, Provides Possible Risk Management Option
A recent study in Ottawa poses a connection between ovarian fibrosis and the risk of developing ovarian cancer, and hints at a drug that may decrease that risk.
Researchers at the University of Washington and four other health institutes explore whether at-home screening tests are an efficient and effective way to detect cervical precancer.
By scrutinizing breast cancer cell lines, tissue grafts and samples, as well as data from The Cancer Genome Atlas, researchers at The Graduate Center of The City University of New York (CUNY) and Hunter College, along with colleagues at Memorial Sloan Kettering Cancer Center and The...
New research pushes back against suggestions that screening mammography may no longer be a primary factor in decreased breast cancer mortality.
In the final results of a major international clinical trial, women with hormone receptor-negative breast cancer who received a combination of standard chemotherapy and hormone treatment were more likely to become pregnant and enjoyed a better five-year survival rate than patients who received chemotherapy alone.
Research presented at a meeting of the Radiological Society of North America (RSNA) adds to existing evidence that women age 75 or older benefit from continued mammography screening, expanding the debate about whether the age recommendations for these screenings should change.
Significant numbers of women for whom hormone therapy (HT) poses little risk stopped undergoing or did not initiate HT based on misinterpretations of a 2002 announcement about safety concerns, new research finds.
The rate of...
A Belgian research team has developed a fibrin matrix that closely resembles human ovarian tissue. The promising result, published in the Journal of Assisted Reproduction and Genetics, brings physicians closer to making artificial ovary transplantation an option for fertility preservation following cancer treatment.
- 1 of 5
- next ›